Chemoinformaics analysis of 5-methyl-5-propylnonane
Molecular Weight | 184.367 | nRot | 8 |
Heavy Atom Molecular Weight | 156.143 | nRig | 0 |
Exact Molecular Weight | 184.219 | nRing | 0 |
Solubility: LogS | -6.312 | nHRing | 0 |
Solubility: LogP | 6.505 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 40.3802 |
nHD | 0 | BPOL | 28.0898 |
QED | 0.488 |
Synth | 2.38 |
Natural Product Likeliness | 0.263 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.034 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.429 |
MDCK | 0.00000993 |
BBB | 0.331 |
PPB | 0.975917 |
VDSS | 2.436 |
FU | 0.028239 |
CYP1A2-inh | 0.371 |
CYP1A2-sub | 0.85 |
CYP2c19-inh | 0.499 |
CYP2c19-sub | 0.938 |
CYP2c9-inh | 0.231 |
CYP2c9-sub | 0.941 |
CYP2d6-inh | 0.245 |
CYP2d6-sub | 0.392 |
CYP3a4-inh | 0.28 |
CYP3a4-sub | 0.122 |
CL | 4.414 |
T12 | 0.125 |
hERG | 0.101 |
Ames | 0.003 |
ROA | 0.055 |
SkinSen | 0.42 |
Carcinogencity | 0.049 |
EI | 0.923 |
Respiratory | 0.371 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.588317 |